Course and extent of variation of equine infectious anemia virus during parallel persistent infections.
Abstract: Comparisons of peptide and oligonucleotide maps of glycoproteins and RNA from nine isolates of equine infectious anemia virus (EIAV) that were generated during parallel infections of two Shetland ponies revealed that each isolate was structurally unique. Each EIAV isolate contained a unique subset of variant peptides, oligonucleotides, or both, indicating that structural variation in EIAV is a random and noncumulative process and that a large spectrum of possible EIAV variants can be generated in infected animals.
Publication Date: 1987-04-01 PubMed ID: 3029423PubMed Central: PMC254092DOI: 10.1128/JVI.61.4.1266-1270.1987Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
- Research Support
- U.S. Gov't
- P.H.S.
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article examines how the equine infectious anemia virus (EIAV) varies in structure during different, simultaneous infections in two Shetland ponies.
Research Objective
- The purpose of this research was to investigate how the Equine Infectious Anemia Virus (EIAV) evolves in structure during parallel infections. To understand this, researchers took samples from nine different EIAV cases.
Methodology
- The team analyzed samples using peptide and oligonucleotide maps. Peptides (chains of amino acids) and oligonucleotides (short sequences of nucleotides) were compared through mapping to identify evolutionary changes in the virus structure.
- These samples were drawn from two Shetland ponies. The two subjects provided a controlled environment for the investigation, enabling researchers to observe structural changes in similar situations.
Findings
- The research found that each of the analysed EIAV samples was structurally unique. This structural difference was seen at the level of distinct variants of peptides and oligonucleotides present in each isolate.
- The findings suggest that the structural variation in EIAV is random and noncumulative. This indicates that the changes seen in the virus do not build upon previous versions and each variation is unique and independent.
- This observation further alludes to the possibility that a wide variety of EIAV variants can be produced in infected animals.
Implications
- The results from this study contribute to the overall understanding of the equine infectious anemia virus. The discovery that each virus isolate is structurally unique could have implications for the development of treatments or vaccines. This could potentially mean that a single treatment or vaccine may not be effective for all variants of the virus.
- The noncumulative nature of the virus and the potential for a large number of variants may pose challenges in combating the disease and prevent a straightforward solution.
Cite This Article
APA
Payne SL, Salinovich O, Nauman SM, Issel CJ, Montelaro RC.
(1987).
Course and extent of variation of equine infectious anemia virus during parallel persistent infections.
J Virol, 61(4), 1266-1270.
https://doi.org/10.1128/JVI.61.4.1266-1270.1987 Publication
Researcher Affiliations
MeSH Terms
- Animals
- Equine Infectious Anemia / microbiology
- Genetic Variation
- Horses
- Infectious Anemia Virus, Equine / genetics
- Peptide Fragments / analysis
- Trypsin
- Viral Envelope Proteins / genetics
- Viral Envelope Proteins / isolation & purification
Grant Funding
- CA-38851 / NCI NIH HHS
References
This article includes 18 references
- Kono Y, Kobayashi K, Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses.. Arch Gesamte Virusforsch 1973;41(1):1-10.
- Salinovich O, Montelaro RC. Comparison of glycoproteins by two-dimensional mapping of glycosylated peptides.. Anal Biochem 1986 Aug 15;157(1):19-27.
- Clements JE, Pedersen FS, Narayan O, Haseltine WA. Genomic changes associated with antigenic variation of visna virus durig persistent infection.. Proc Natl Acad Sci U S A 1980 Aug;77(8):4454-8.
- Parekh B, Issel CJ, Montelaro RC. Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses.. Virology 1980 Dec;107(2):520-5.
- Montelaro RC, Lohrey N, Parekh B, Blakeney EW, Issel CJ. Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus.. J Virol 1982 Jun;42(3):1029-38.
- Clements JE, D'Antonio N, Narayan O. Genomic changes associated with antigenic variation of visna virus. II. Common nucleotide sequence changes detected in variants from independent isolations.. J Mol Biol 1982 Jul 5;158(3):415-34.
- Orrego A, Issel CJ, Montelaro RC, Adams WV Jr. Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies.. Am J Vet Res 1982 Sep;43(9):1556-60.
- Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, Mann D, Sidhu GD, Stahl RE, Zolla-Pazner S, Leibowitch J, Popovic M. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS).. Science 1983 May 20;220(4599):865-7.
- Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).. Science 1983 May 20;220(4599):868-71.
- Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.. Science 1984 May 4;224(4648):497-500.
- Payne S, Parekh B, Montelaro RC, Issel CJ. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus.. J Gen Virol 1984 Aug;65 ( Pt 8):1395-9.
- Montelaro RC, Parekh B, Orrego A, Issel CJ. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.. J Biol Chem 1984 Aug 25;259(16):10539-44.
- Wong-Staal F, Shaw GM, Hahn BH, Salahuddin SZ, Popovic M, Markham P, Redfield R, Gallo RC. Genomic diversity of human T-lymphotropic virus type III (HTLV-III).. Science 1985 Aug 23;229(4715):759-62.
- Salinovich O, Payne SL, Montelaro RC, Hussain KA, Issel CJ, Schnorr KL. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.. J Virol 1986 Jan;57(1):71-80.
- Hahn BH, Shaw GM, Taylor ME, Redfield RR, Markham PD, Salahuddin SZ, Wong-Staal F, Gallo RC, Parks ES, Parks WP. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.. Science 1986 Jun 20;232(4757):1548-53.
- Alizon M, Wain-Hobson S, Montagnier L, Sonigo P. Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.. Cell 1986 Jul 4;46(1):63-74.
- Haase AT. Pathogenesis of lentivirus infections.. Nature 1986 Jul 10-16;322(6075):130-6.
- Issel CJ, Coggins L. Equine infectious anemia: current knowledge.. J Am Vet Med Assoc 1979 Apr 1;174(7):727-33.
Citations
This article has been cited 26 times.- Wang HN, Rao D, Fu XQ, Hu MM, Dong JG. Equine infectious anemia virus in China.. Oncotarget 2018 Jan 2;9(1):1356-1364.
- Craigo JK, Montelaro RC. Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.. Viruses 2013 Dec 2;5(12):2963-76.
- Craigo JK, Barnes S, Zhang B, Cook SJ, Howe L, Issel CJ, Montelaro RC. An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.. Retrovirology 2009 Oct 20;6:95.
- Payne SL, Pei XF, Jia B, Fagerness A, Fuller FJ. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.. J Virol 2004 Mar;78(5):2478-85.
- Leroux C, Craigo JK, Issel CJ, Montelaro RC. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.. J Virol 2001 May;75(10):4570-83.
- Leroux C, Issel CJ, Montelaro RC. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.. J Virol 1997 Dec;71(12):9627-39.
- Zheng YH, Sentsui H, Nakaya T, Kono Y, Ikuta K. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain.. J Virol 1997 Jul;71(7):5031-9.
- Lichtenstein DL, Issel CJ, Montelaro RC. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.. J Virol 1996 Jun;70(6):3346-54.
- Sellon DC. Equine infectious anemia.. Vet Clin North Am Equine Pract 1993 Aug;9(2):321-36.
- Kim CH, Casey JW. In vivo replicative status and envelope heterogeneity of equine infectious anemia virus in an inapparent carrier.. J Virol 1994 Apr;68(4):2777-80.
- Sellon DC, Fuller FJ, McGuire TC. The immunopathogenesis of equine infectious anemia virus.. Virus Res 1994 May;32(2):111-38.
- Steinhauer DA, de la Torre JC, Meier E, Holland JJ. Extreme heterogeneity in populations of vesicular stomatitis virus.. J Virol 1989 May;63(5):2072-80.
- Hussain KA, Issel CJ, Schnorr KL, Rwambo PM, West M, Montelaro RC. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.. Arch Virol 1988;98(3-4):213-24.
- Hussain KA, Issel CJ, Schnorr KL, Rwambo PM, Montelaro RC. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.. J Virol 1987 Oct;61(10):2956-61.
- Whetter L, Archambault D, Perry S, Gazit A, Coggins L, Yaniv A, Clabough D, Dahlberg J, Fuller F, Tronick S. Equine infectious anemia virus derived from a molecular clone persistently infects horses.. J Virol 1990 Dec;64(12):5750-6.
- Rwambo PM, Issel CJ, Adams WV Jr, Hussain KA, Miller M, Montelaro RC. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.. Arch Virol 1990;111(3-4):199-212.
- Balfe P, Simmonds P, Ludlam CA, Bishop JO, Brown AJ. Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations.. J Virol 1990 Dec;64(12):6221-33.
- Chong YH, Ball JM, Issel CJ, Montelaro RC, Rushlow KE. Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus.. J Virol 1991 Feb;65(2):1013-8.
- Clabough DL, Gebhard D, Flaherty MT, Whetter LE, Perry ST, Coggins L, Fuller FJ. Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus.. J Virol 1991 Nov;65(11):6242-51.
- Kodama T, Burns DP, Silva DP, Veronese FD, Desrosiers RC. Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus.. J Virol 1991 Apr;65(4):2010-8.
- Chong YH, Payne SL, Issel CJ, Montelaro RC, Rushlow KE. Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus.. J Virol 1991 Feb;65(2):1007-12.
- Rwambo PM, Issel CJ, Hussain KA, Montelaro RC. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV).. Arch Virol 1990;111(3-4):275-80.
- Shimizu N, Takeuchi Y, Naruse T, Inagaki M, Moriyama E, Gojobori T, Hoshino H. Six strains of human immunodeficiency virus type 1 isolated in Japan and their molecular phylogeny.. J Mol Evol 1992 Oct;35(4):329-36.
- Sellon DC, Perry ST, Coggins L, Fuller FJ. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes.. J Virol 1992 Oct;66(10):5906-13.
- Ball JM, Rushlow KE, Issel CJ, Montelaro RC. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.. J Virol 1992 Feb;66(2):732-42.
- Perry ST, Flaherty MT, Kelley MJ, Clabough DL, Tronick SR, Coggins L, Whetter L, Lengel CR, Fuller F. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro.. J Virol 1992 Jul;66(7):4085-97.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists